• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

DIHYDROXYPHENYLALANINE

Drugs for Parkinson’s and Alzheimer’s

August 27, 2018Alzheimer's, Nervous System Disorders, Parkinson's, Vizit Graphs
Drugs for Parkinson’s and Alzheimer’s

Find drugs common to both Parkinson’s and Alzheimer’s diseases using Biovista Vizit. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

STREPTOCOCCUS PNEUMONIAE CTLA4 AUTOPHAGY CASP3 CANCER SOD1 DIABETES MELLITUS 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE IFNG DOXORUBICIN INFLAMMATION LISTERIA MONOCYTOGENES CANDIDA ALBICANS PSEUDOMONAS AERUGINOSA STAPHYLOCOCCUS AUREUS IL6 REMICADE PORPHYROMONAS GINGIVALIS METFORMIN CELL DIVISION ANGIOGENESIS TH17 CELLS ESCHERICHIA COLI NEURODEGENERATIVE DISORDERS IL17A CLOSTRIDIUM DIFFICILE ERBB-2 CELL DIFFERENTIATION APOPTOTIC PROCESS INSULIN BREAST CANCER CD4 TP53 CELL PROLIFERATION CELL DEATH HELICOBACTER PYLORI ALZHEIMER'S DISEASE PARKINSON DISEASE FOXP3 IL23A TNF AGING RECEPTOR IMMUNE RESPONSE RHEUMATOID ARTHRITIS

© 2019 Biovista Vizit All Rights Reserved.